13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001922318
Total reported value
$1.4B
$1.4B
54 檔
49.2%
During the Q3 2025 filing period, Pale Fire Capital SE (CIK: 0001922318) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $1.4B across 54 reported positions.
In Q3 2025, Pale Fire Capital SE adopted a defensive or profit-taking posture, trimming 17 positions and completely liquidating 26 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BTG | B2gold CORP | Stock-Other | 27.10% | -10.69% | -23.94% | |
| 2 | GRPN | Groupon Inc | Stock-Other | 26.02% | +6.67% | — | |
| 3 | DOLE | Dole plc | Stock-Other | 12.63% | -2.69% | +39.09% | |
| 4 | IAG | Iamgold CORP | Stock-Other | 5.56% | — | +197.56% | |
| 5 | NGDN | New Gold Inc | Stock-Other | 4.88% | — | +10.31% | |
| 6 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 3.74% | — | +60.84% | |
| 7 | CGAU | Centerra Gold Inc | Stock-Other | 2.74% | — | -32.63% | |
| 8 | ANGI | Angi Inc | Stock-Other | 2.44% | -0.72% | +5.88% | |
| 9 | IAUX | I-80 Gold CORP | Stock-Other | 2.36% | -0.86% | +5.90% | |
| 10 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 2.21% | +0.30% | +19.21% | |
| 11 | ZD | Ziff Davis Inc | Stock-Other | 1.68% | -0.41% | +17.19% | |
| 12 | GAU | Galiano Gold Inc | Stock-Other | 1.60% | -0.21% | +10.71% | |
| 13 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 0.83% | — | -5.50% | |
| 14 | ATAI | AtaiBeckley Inc. | Stock-Other | 0.63% | — | -59.07% | |
| 15 | LQDA | Liquidia CORP | Stock-Other | 0.60% | -1.27% | +180.89% | |
| 16 | KURA | Kura Oncology Inc | Stock-Other | 0.59% | -0.57% | +2923.83% | |
| 17 | NUVB | Nuvation Bio Inc | Stock-Other | 0.59% | — | +1410.47% | |
| 18 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.45% | — | — | |
| 19 | INSW | International Seaways, Inc. | Stock-Other | 0.38% | — | -71.74% | |
| 20 | SSTK | Shutterstock Inc | Stock-Other | 0.35% | — | — | |
| 21 | GERN | Geron CORP | Stock-Other | 0.34% | -0.16% | — | |
| 22 | RGNX | Regenxbio Inc | Stock-Other | 0.27% | +0.03% | +817.91% | |
| 23 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.23% | — | +768.09% | |
| 24 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.20% | — | — | |
| 25 | AVU0 | Adverum Biotechnologies Inc | Stock-Other | 0.18% | — | +1.27% | |
| 26 | DERM | Journey Medical CORP | Stock-Other | 0.18% | +0.06% | +604.19% | |
| 27 | CMRC | Commerce.com Inc | Stock-Other | 0.16% | -0.05% | — | |
| 28 | HELP | Cybin Inc | Stock-Other | 0.10% | +0.01% | +36.08% | |
| 29 | ✓ | Adeco Agro | Stock-Other | 0.07% | — | — | |
| 30 | ✓ | Spdr Index Shs Fds | Stock-Other | 0.07% | — | — | |
| 31 | XFOR | X4 Pharmaceuticals Inc | Stock-Other | 0.07% | -0.06% | EXIT | |
| 32 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.06% | -0.11% | — | |
| 33 | NVDA | NVIDIA Corporation | Stock-Tech | 0.06% | — | -97.09% | |
| 34 | QDEL | Quidelortho CORP | Stock-Other | 0.06% | — | — | |
| 35 | AQST | Aquestive Therapeutics Inc | Stock-Other | 0.06% | — | -94.44% | |
| 36 | LFCR | Lifecore Biomedical Inc | Stock-Other | 0.05% | — | +110.58% | |
| 37 | PESI | Perma-fix Environmental Svcs | Stock-Other | 0.05% | +0.01% | +76.22% | |
| 38 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.05% | +0.01% | — | |
| 39 | ETNBGBP | 89bio Inc | Stock-Other | 0.04% | — | +1.22% | |
| 40 | RZLT | Rezolute Inc | Stock-Other | 0.04% | — | -14.66% | |
| 41 | HROW | Harrow Inc | Stock-Other | 0.04% | — | -6.79% | |
| 42 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 0.04% | — | -25.41% | |
| 43 | ✓ | Immatics NV | Stock-Other | 0.03% | -0.01% | EXIT | |
| 44 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.02% | — | +21.70% | |
| 45 | MITT | Tpg Mortgage Investment Trus | Stock-Other | 0.02% | — | -39.99% | |
| 46 | MUX | Mcewen Inc | Stock-Other | 0.02% | — | +2.79% | |
| 47 | BHVN | Biohaven Ltd. | Stock-Other | 0.02% | — | — | |
| 48 | LRMR | Larimar Therapeutics Inc | Stock-Other | 0.02% | +0.01% | NEW | |
| 49 | AKBA | Akebia Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 50 | VZLA | Vizsla Silver CORP | Stock-Other | 0.01% | — | -20.80% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BTG | B2gold CORP | +5.1% | -23.94% | Trim |
| 2 | GRPN | Groupon Inc | +3.3% | — | Unchanged |
| 3 | NGDN | New Gold Inc | +2% | +10.31% | Trim |
| 4 | DOLE | Dole plc | +1.9% | +39.09% | Add |
| 5 | ANGI | Angi Inc | +1.6% | +5.88% | Add |
| 6 | MLYS | Mineralys Therapeutics Inc | +1.5% | +19.21% | Add |
| 7 | IAUX | I-80 Gold CORP | +1.2% | +5.90% | Add |
| 8 | GAU | Galiano Gold Inc | +1.1% | +10.71% | Add |
| 9 | NUVB | Nuvation Bio Inc | +0.6% | +1410.47% | Add |
| 10 | ZD | Ziff Davis Inc | +0.6% | +17.19% | Add |
| 11 | RGNX | Regenxbio Inc | +0.3% | +817.91% | Add |
| 12 | ATAI | AtaiBeckley Inc. | +0.2% | -59.07% | Trim |
| 13 | DAWNGBX | Day One Biopharmaceuticals I | +0.2% | +768.09% | Add |
| 14 | SSTK | Shutterstock Inc | +0.2% | — | Add |
| 15 | DERM | Journey Medical CORP | +0.2% | +604.19% | Add |
| 16 | CGAU | Centerra Gold Inc | +0.1% | -32.63% | Trim |
| 17 | TEN | Tsakos Energy Navigation Limited | +0.1% | -5.50% | Trim |
| 18 | CRBU | Caribou Biosciences Inc | +0.1% | — | Trim |
| 19 | PESI | Perma-fix Environmental Svcs | 0% | +76.22% | Add |
| 20 | RZLT | Rezolute Inc | 0% | -14.66% | Trim |
| 21 | ETNBGBP | 89bio Inc | 0% | +1.22% | Add |
| 22 | ARWR | Arrowhead Pharmaceuticals In | 0% | -25.41% | Trim |
| 23 | HELP | Cybin Inc | 0% | +36.08% | Add |
| 24 | HROW | Harrow Inc | 0% | -6.79% | Trim |
| 25 | LXEO | Lexeo Therapeutics Inc | 0% | +21.70% | Add |
| 26 | ✓ | Immatics NV | 0% | — | Unchanged |
| 27 | LRMR | Larimar Therapeutics Inc | 0% | +20.52% | Add |
| 28 | VZLA | Vizsla Silver CORP | — | -20.80% | Trim |
| 29 | ✓ | Engene Holdings Inc | — | — | Unchanged |
| 30 | ODV | Osisko Development CORP | — | -56.93% | Trim |
| 31 | NEWP | New Pacific Metals CORP | — | -61.59% | Trim |
| 32 | AVU0 | Adverum Biotechnologies Inc | 0% | +1.27% | Trim |
| 33 | MITT | Tpg Mortgage Investment Trus | 0% | -39.99% | Trim |
| 34 | AQST | Aquestive Therapeutics Inc | -0.4% | -94.44% | Trim |
| 35 | INSW | International Seaways, Inc. | -0.7% | -71.74% | Trim |
| 36 | NVDA | NVIDIA Corporation | -1.3% | -97.09% | Trim |
| 37 | ABX | Barrick Gold CORP | — | EXIT | Sold out |
| 38 | IAG | Iamgold CORP | — | NEW | New buy |
| 39 | HL | Hecla Mining Co | — | EXIT | Sold out |
| 40 | TEVA | Teva Pharmaceutical-sp Adr | — | NEW | New buy |
| 41 | CDE | Coeur Mining Inc | — | EXIT | Sold out |
| 42 | PAAS | Pan American Silver CORP | — | EXIT | Sold out |
| 43 | LQDA | Liquidia CORP | — | NEW | New buy |
| 44 | KURA | Kura Oncology Inc | — | NEW | New buy |
| 45 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 46 | TECX | Tectonic Therapeutic Inc | — | NEW | New buy |
| 47 | OCUL | Ocular Therapeutix Inc | — | EXIT | Sold out |
| 48 | GERN | Geron CORP | — | NEW | New buy |
| 49 | CIM | Chimera Investment CORP | — | EXIT | Sold out |
| 50 | UBER | Uber Technologies Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 54 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BTG, GRPN, DOLE) accounted for 49.2% of total reported equity market value during Q3 2025.
Top New Position Initiated
IAG
市值: $50.8M
Top Position Liquidated / Trimmed
ABX
前期市值: $145.8M
During Q3 2025, Pale Fire Capital SE's top holdings by market value included BTG (27.1%)、GRPN (26.0%)、DOLE (12.6%). The largest single position, BTG, represented 27.1% of total portfolio value.
In Q3 2025, Pale Fire Capital SE made 77 total portfolio adjustments, initiating 18 new buys, adding to 16 positions, trimming 17 holdings, and fully liquidating 26 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.